CMAJ • March 17, 2009; 180 (6). doi:10.1503/cmaj.1080130.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forster, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forster, M.
Related Collections
Right arrow Other gastroenterology
Right arrow Osteoporosis

Letters

Proton pump inhibitors and osteoporosis-related fractures

Mathieu Forster, MD MSc

Centre hospitalier régional de Lanaudière, Joliette, Que.

In an important and interesting study, Laura Targownik and colleagues1 state that the effect of exposure to proton pump inhibitors on osteoporosis-related fractures might be "similar in size to [the effect of] other established osteoporotic-fracture risk factors, such as smoking, low body mass index and excessive alcohol intake." However, the authors did not take any of these factors into account in their analysis. Were the case and control groups comparable in terms of these 3 variables? If not, what is the role of these variables in the observed associations? For example, people who use proton pump inhibitors might be less likely to be active smokers because of gastresophageal reflux disease but, at the same time, they could be more likely to have a history of smoking than people who do not use this class of drugs.

This may have an impact (of unknown magnitude) on the estimation of the effect of proton pump inhibitors.

This study relies on the analysis of administrative data, which were probably collected for purposes quite distinct from research into the causes of osteoporosis. This does not mean that such data are inadequate for health research, but that we should be more critical about the inferences drawn from them.

Footnotes

Competing interests: None declared.


REFERENCE

  1. Targownik LE, Lix LM, Metge CJ, et al. Use of proton pump inhibitors and risk of osteoporosis- related fractures. CMAJ 2008;179:319-26.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forster, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forster, M.
Related Collections
Right arrow Other gastroenterology
Right arrow Osteoporosis